SCHEMBL6940824

SCHEMBL6940824

Cc1cccc(C)c1NC(=O)Nc1ccccc1Sc1ccc(N)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.52
DDX3X O00571 2/20 0.47
TDP1 Q9NUW8 2/20 0.46
HPGD P15428 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPT P10636 4/20 0.45
ALDH1A1 P00352 7/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 5/20 0.43
BLM P54132 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NOD2 Q9HC29 1/20 0.43
KMT2A Q03164 5/20 0.43
MEN1 O00255 3/20 0.43
ATM Q13315 1/20 0.42
DRD2 P14416 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2B P41595 1/20 0.42
HTT P42858 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6939614 0.83 DDX3X (0.51) L3MBTL1DDX3XTDP1HPGDMAPT
SCHEMBL6940827 0.81 KMT2A (0.58) DDX3XHPGDMAPTALDH1A1SMN1; SMN2
SCHEMBL6937514 0.80 MEN1 (0.65) L3MBTL1TDP1HPGDCYP2C9CYP2C19
SCHEMBL6934961 0.75 RAB9A (0.54) L3MBTL1MAPTALDH1A1SMN1; SMN2KMT2A
SCHEMBL7070334 0.74 GAA (0.56) L3MBTL1DDX3XTDP1MAPTALDH1A1
SCHEMBL6941536 0.73 DDX3X (0.57) L3MBTL1DDX3XTDP1HPGDMAPT
SCHEMBL27688984 0.73 TDP1 (0.49) L3MBTL1TDP1HPGDCYP2C9CYP2C19
SCHEMBL18620896 0.72 CYP3A4 (0.52) L3MBTL1TDP1HPGDCYP2C9CYP2C19
SCHEMBL30051979 0.72 MAPT (0.67) L3MBTL1CYP2C9CYP2C19MAPTALDH1A1
SCHEMBL3460449 0.70 DDX3X (0.70) L3MBTL1DDX3XHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042278-B1 1,3-DISUBSTITUTED UREAS AS ACAT INHIBITORS, AND METHOD OF PREPARING THEREOF SLOVAKOFARMA AS (SK) 2003-03-05 EP disclosed
US-6444691-B1 ANTICHOLESTEROL AGENTS SOLVAKOFARMA, A.S. (SK) 2002-09-03 US disclosed
EP-1042278-A1 1,3-DISUBSTITUTED UREAS AS ACAT INHIBITORS, AND METHOD OF PREPARING THEREOF Slovakofarma, A.S. (SK) 2000-10-11 EP disclosed
WO-1999032437-A1 1,3-DISUBSTITUTED UREAS AS ACAT INHIBITORS, AND METHOD OF PREPARING THEREOF SLOVAKOFARMA, A.S. (SK) 1999-07-01 WO disclosed